Geneos Wealth Management’s Capital Group Core Equity ETF CGUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.5M Buy
191,173
+28,794
+18% +$1.23M 0.17% 132
2026
Q1
$6.24M Buy
162,379
+15,756
+11% +$634K 0.14% 169
2025
Q4
$5.9M Buy
146,623
+11,865
+9% +$474K 0.14% 175
2025
Q3
$5.33M Sell
134,758
-5,743
-4% -$221K 0.14% 194
2025
Q2
$5.19M Buy
140,501
+133,134
+1,807% +$4.54M 0.13% 203
2025
Q1
$246K Buy
7,367
+5,194
+239% +$182K 0.01% 836
2024
Q4
$76K Buy
2,173
+1,143
+111% +$40.1K ﹤0.01% 1157
2024
Q3
$35.3K Buy
1,030
+709
+221% +$23.4K ﹤0.01% 1324
2024
Q2
$10.4K Buy
+321
New +$10K ﹤0.01% 1542
2022
Q3
Sell
-548
Closed -$11K 2096
2022
Q2
$11K Buy
+548
New +$12.9K ﹤0.01% 1897

Other funds holding CGUS

Geneos Wealth Management's CGUS Position: Q2 2026 in Review

Geneos Wealth Management increased its Capital Group Core Equity ETF (CGUS) stake by 18% in Q2 2026, buying an estimated $1.23M and bringing the position to 191,173 shares worth $8.5M. The position accounts for 0.17% of the portfolio, ranked #132.

Geneos Wealth Management first reported a position in CGUS in Q2 2022 and has held it in 10 quarters since. 442 funds tracked by Wall St. Rank hold CGUS as of Q2 2026.

  • Geneos Wealth Management held 191,173 shares of Capital Group Core Equity ETF worth $8.5M as of Q2 2026.
  • Geneos Wealth Management bought 28,794 Capital Group Core Equity ETF shares in Q2 2026, an estimated $1.23M.
  • Capital Group Core Equity ETF made up 0.17% of Geneos Wealth Management's portfolio in Q2 2026, its #132 holding.
  • Geneos Wealth Management first reported a position in Capital Group Core Equity ETF in Q2 2022 and has held it in 10 quarters since.
  • 442 funds tracked by Wall St. Rank held Capital Group Core Equity ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.